These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10867532)

  • 21. Post-prandial carbohydrate modulation via gut--Indian perspective.
    Joshi SR
    J Assoc Physicians India; 2010 Nov; 58():665. PubMed ID: 21510457
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria.
    Yongwatana K; Supasyndh O; Satirapoj B
    J Diabetes Res; 2020; 2020():2984680. PubMed ID: 32851094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
    Holman RR; Bethel MA; Chan JC; Chiasson JL; Doran Z; Ge J; Gerstein H; Huo Y; McMurray JJ; Ryden L; Liyanage W; Schröder S; Tendera M; Theodorakis MJ; Tuomilehto J; Yang W; Hu D; Pan C;
    Am Heart J; 2014 Jul; 168(1):23-9.e2. PubMed ID: 24952856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of jiawei shenqi dihuang tang on the content of urinary protein in patients with diabetic nephropathy.
    Chen Y; Wei L; Ma M; Wu G; Zhang G; Wei Z
    J Tradit Chin Med; 1997 Sep; 17(3):184-6. PubMed ID: 10437191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.
    Detournay B; Simon D; Guillausseau PJ; Joly D; Verges B; Attali C; Clement O; Briand Y; Delaitre O
    Diabetes Metab; 2012 Apr; 38(2):102-12. PubMed ID: 22252014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Shimada N; Ohmuro H; Ebihara I; Koide H
    Nephron; 1999; 83(4):361-2. PubMed ID: 10575300
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
    Matsumura M; Monden T; Miyashita Y; Kawagoe Y; Shimizu H; Nakatani Y; Domeki N; Yanagi K; Ikeda S; Kasai K
    Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive treatment with acarbose in diabetic reactive hypoglycemia.
    Lee A
    J Am Med Dir Assoc; 2010 Jun; 11(5):377-8. PubMed ID: 20511106
    [No Abstract]   [Full Text] [Related]  

  • 31. Thiamine in diabetic nephropathy: a novel treatment modality?
    Alkhalaf A; Kleefstra N; Groenier KH; Bakker SJ; Navis GJ; Bilo HJ
    Diabetologia; 2009 Jun; 52(6):1212-3; author reply 1214-6. PubMed ID: 19296076
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats.
    Kurundkar SB; Sachan N; Kodam KM; Kulkarni VM; Bodhankar SL; D'Souza S; Vanage G; Ghole VS
    J Diabetes; 2010 Dec; 2(4):282-9. PubMed ID: 20923502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes mellitus, cardiovascular sequelae and acarbose. Introductory Address by the German Diabetes Society].
    Schatz H
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():20. PubMed ID: 14694839
    [No Abstract]   [Full Text] [Related]  

  • 34. SGLT2 inhibitors and renal function.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):91-2. PubMed ID: 27403782
    [No Abstract]   [Full Text] [Related]  

  • 35. Acarbose for patients with hypertension and impaired glucose tolerance.
    Rosenthal JH
    JAMA; 2003 Dec; 290(23):3066; author reply 3067-9. PubMed ID: 14679262
    [No Abstract]   [Full Text] [Related]  

  • 36. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
    Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral hypoglycemics and diabetic nephropathy.
    Hadler NM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):159-62. PubMed ID: 18178782
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
    Gorson DM
    Diabetes Care; 1998 Dec; 21(12):2190-1. PubMed ID: 9839116
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study.
    Hanefeld M; Schaper F; Koehler C; Bergmann S; Ugocsai P; Stelzer J; Schmitz G
    Horm Metab Res; 2009 Feb; 41(2):132-6. PubMed ID: 19214923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.